Affiliation:
1. SEHA Kidney Care Abu Dhabi United Arab Emirates
2. College of Medicine and Health Sciences Khalifa University Abu Dhabi United Arab Emirates
Abstract
AbstractAimWe aimed to better understand the prevalence of chronic kidney disease in Abu Dhabi, UAE, where a very diverse ethnic population lives, each with their own risk profile.MethodsData were analysed on all patients who were tested for serum creatinine in December 2019 for 4 years within our healthcare network. We analysed data for kidney disease by age, gender and nationality to study differences in prevalence and risk.ResultsThe entire cohort (EC) consisted 1 925 672 samples from 703 122 patients. 24% of patients had GFR < 90 mL/min/1.73 m2 (CKD2‐5), 4% had more severe kidney dysfunction (CKD3‐5) and 2% had UACR >3 mg/mmol and with GFR > 90 (CKD1).The long follow‐up (LFU) group comprised 45.6% of patients who had eGFR on at least two occasions more than 90 days apart, and of these 19.5% had sustained eGFR <90, and 5.2% had CKD3‐5.Males had lower eGFR than females in the EC (RR 1.68) and the LFU group (RR 1.76). Emirati Females had the lowest prevalence in the EC (2.9%) and expatriate females in the LFU (3.5%) groups. The relative risks of CKD in expatriate males were highest in the EC (2.14) and the LFU (2.39) groups.When we looked at the age distribution by nationality there were highly significant differences in some populations being highly represented at younger ages.ConclusionThe prevalence of kidney disease in Abu Dhabi has a male predominance, with younger expatriates highly represented. A targeted strategy to identify those at high risk may identify early CKD to prevent progression to end‐stage kidney disease.image
Reference30 articles.
1. Sustainable Development Goals relevant to kidney health: an update on progress
2. European Kidney Health Alliance. Recommendations for Sustainable Kidney Care Report 2015.https://ekha.eu/wp-content/uploads/2016/01/EKHA-Recs-for-Sustainable-Kidney-Care-25.08.2015.pdf
3. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study
4. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: the CaReMe CKD study;Sundström J;Lancet Reg Health Eur,2022
5. United States Renal Data System.USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases Bethesda MD 2022. Accessed January 14 2024.2022https://usrds-adr.niddk.nih.gov/